The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020

Amendment of regulation 229

5.  In regulation 229(1) (exemption for supply by national health service bodies and local authorities)—

(a) in paragraph (1), after “Regulations 214(1)” insert “and (2)”;

(b) after paragraph (2), insert—

“(2A) In relation to a medicinal product that is for parenteral administration, condition A only applies if the person who has given the written directions is an appropriate practitioner in relation to that medicinal product.”;

(c) in paragraph (3)(f), after “is supplied” insert “, either an authorisation by the licensing authority on a temporary basis under regulation 174 or”; and

(d) after paragraph (3), insert—

“(4) The following cease to have effect on 1st April 2022—

(a) in paragraph (1), “and (2)”; and

(b) paragraph (2A).”.

(1)

Paragraph (1) of regulation 229 has been amended by S.I. 2013/235 and 2015/323. Paragraph (3)(f) is to be substituted by S.I. 2019/775 as amended by S.I. 2020/1488.